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Mammalian cell cultures have become a universal path for producing 
therapeutic proteins, monoclonal antibodies in particular, in 
biopharmaceutical industries. There is a constant attempt to improve the 
productivity of the cell cultures through research in the industry and 
educational institutions.  
The productivity of the cells can be improved through various 
techniques. The use of additives is the most economical option to pursue for 
improving the productivity of the cells. The additives, hydrolysates, were used 
in the cell culture at a final concentration of 0.4% and we have seen a two to 
threefold increase in the productivity of the cells. While soy hydrolysate 
doubled the productivity along with the cell growth, cotton hydrolysates have 
increased it three times when compared to the control flasks not supplemented 
with any hydrolysates.  
Five different lots of cotton hydrolysates were tested simultaneously as media 
supplements for a lot variability study. The cotton lots 100NTCR and 
100PCHO performed the best among the five lots tested in terms of both cell 
growth and IgG productivity. Both these lots were selected to perform 
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proteomics analysis on the hydrolysate samples to understand the mode of 
action of these hydrolysates when added to the cell cultures.  
Essential amino acids’ biosynthetic pathways were to be engineered 
into mammalian cells. In particular, the research described in the thesis 
targeted branched chain amino acids- Leucine, Isoleucine and Valine. All the 
genes were cloned into the mammalian expression vector pBUD4.1 and later 
transfected into CHO-K1 and HEK 293T cell lines and their expression was 
tested using a western blot. Five out of the nine genes to be expressed, have 
worked. This opens up new avenues to explore the machinery in the 
mammalian cell and lead to the synthesis of a minimal cell. 
Advisor: Dr. Michael Betenbaugh 
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Chapter 1 INTRODUCTION 
 
1.1 Objective of the Thesis 
This thesis aims to develop processes which would improve the 
productivity of therapeutic proteins in mammalian cell cultures, especially 
Chinese Hamster Ovary (CHO) cell lines. Therapeutic proteins are produced 
using mammalian cells for the sole reason that they have to be compatible to 
the human body once injected into them. Chinese Hamster Ovary cells in 
particular produces proteins with a similar glycosylation pattern to the human 
cells. Having a compatible glycosylation pattern improves the efficacy of the 
therapeutic protein thus enabling its proper intended function in the human 
body.  
Improving the productivity of monoclonal antibodies in CHO cells has 
been a burning problem since the time these cells were known to secrete these 
molecules. Even today, there is a gap between the raw material input and the 
product output from these cell cultures leading to the high cost of these 
therapeutics in the market. Keeping this broad aim in mind, this thesis has 
used various techniques in mammalian cell culture and molecular biology to 
achieve its two main objectives (to be described in the next paragraphs). All 
thesis techniques have been explained along with the protocols used in 
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Chapter 2. The two objectives whose end result would be to improve the 
productivity of the mammalian cell foro the backbone of the thesis. 
Objective 1: Addition of plant hydrolysates to improve the 
productivity of monoclonal antibody in CHO cells. In Chapter 3, mammalian 
cell culture techniques are employed to test the effect of plant hydrolysates on 
CHO cell cultures. The growth and productivity of the cultures are monitored 
to compare and contrast the impact of adding the hydrolysates from two 
different plant sources into a given cell culture media. The various lots of one 
plant source are also compared to provide a lot to lot variability when they are 
added to a culture media. 
Objective 2: Engineering mammalian cells to express prokaryotic 
amino acid biosynthetic genes, thereby reducing the external supplementation 
of nutrients in the form of cell culture media rich in amino acids. In Chapter 
4, molecular cloning is used to enable expression of the biosynthetic genes of 
essential amino acids from prokaryotic species (yeast), in mammalian cell 
lines like HEK and CHO-K1. The pathway genes of three branched chain 
amino acids have been cloned into mammalian expression vectors and tested 
for expression after transfection into CHO and HEK cell lines.  
Chapter 5 summarizes the research work described in the previous 
chapters. Both the objectives include and involve extensive studies and thus 
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needs future work and improvements which have been described at the end of 
Chapter 3 and Chapter 4. These future objectives points to the fact that there 
is a wider scope to the abovementioned objectives which will be explored in 
the days to come. 
 
1.2 Mammalian cell culture 
We know that cells need a suitable environment to grow, which is 
provided by the living organism in which the cell resides. In the twentieth 
century, biologists began to provide this environment outside the living 
organism in the form of tissue culture. They started to believe that cells could 
also be cultivated and kept living even after the organism dies. This fact that 
we know today was just an idea hypothesized by Claude Bernard in 1878 [1]. 
Even though Bernard created this idea, it was put in practice by Ross 
Granville Harrison in 1907, working at Johns Hopkins Medical School, when 
he could grow nerve cells of frogs in sterile cultures in vitro. He named his 
breakthrough in biology research as “hanging drop” experiment and the cell 
culture of the nerve cells lasted for up to four weeks. This method created by 
Harrison was later used by his student Burrows, to establish the mammalian 
cell culture with chick embryos as the cell component of the culture and blood 
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plasma which has clotted as the cell culture media or nutrients supplement 
component of the culture. (Hydrolysate thesis) Since then, in vitro culturing 
of mammalian cells has been developed extensively [2]. 
After a great invention, several questions arise which lead to the 
betterment of the invention along with using the invention for a practical 
application. The same group of people thought of such questions associated 
with cell culture, which led to the concepts of sub-culturing of cells and 
changing media of cell cultures referred by them as media-exchange. Using 
complex media, they were able to subculture and maintain cultures for several 
months. They worked not only with normal adult mammalian tissues, but also 
with cancerous tissues. Various cell types and cell lines have been developed 
by them later using these in vitro culture techniques, epithelial cells, tumor 
cells to name a few [3]. These novel methods were a point of difference 
between Burrows’ and Harrison's research and gave way to introduce the idea 
of continuous culture. These are the cultures created from the old ones, rather 
than starting primary cultures from new tissue explants. This continuous 
passage method to maintain cells could establish that cells could survive in 
vitro for days together provided depletion of nutrients is avoided through 




After further advancement of research which was successful in 
generating new continuous cultures, it was observed that these cell cultures 
(after multiple passages) were morphologically different from the actual 
tissues from which the culture was developed. These morphologically 
different cells were termed to be ‘transformed cell lines’. In 1951, the first 
human "transformed" cell line was developed from a patient who died with 
cervical carcinoma and the cell line was named the HeLa cell [4]. The 
immortality of HeLa cell line marked the beginning of modern cell culture.  
The latter half of the twentieth century saw the development of other 
techniques that are commonly used to culture cells in the modern day like the 
use of trypsin to treat attached cells and passage them into on flask to the 
other, culturing cells in bioreactors, cryopreservation and subsequent revival 
of cells from cold preservation. Eagle started the development of cell culture 
media which needed supplementation of animal serum for adherent cultures 
[5]. Later, Eagle MEM and DMEM have become the standard media for 
mammalian cell culture.  
Using cell cultures for production of biomolecules that are 
commercially important began with the production of vaccine for polio. 
Today, mammalian cell cultures are used for producing various biomolecules 
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important to mankind. As we have seen there are two major components to a 
mammalian cell culture: the cells the needs to be grown and the cell medium 
necessary for growth. There can be two major types of in vitro cell cultures 
based on their source. The first kind, primary cultures are obtained directly 
from the tissue of the organ. These cultures are difficult to maintain since their 
cell growth and division is slow. Such cultures are created aseptically from 
tissues of mammalian hosts which are embryonic, malignant of normal in 
nature.  
After the first subculture, they are no longer considered as primary 
cultures. Such cultures have cells which are of different types since it is 
difficult to isolate one particular type from the tissue samples. Primary cell 
cultures are predominantly adherent in nature. These cultures cannot sustain 
without animal serum in the culture media. The present thesis has not utilized 
any of the primary cell cultures for research as these cultures are used for 
research involving genetics, morphological studies and other basic biology 
research.  
The second type of cultures are, continuous cell lines which are 
created through following series of sub-culturing from the primary cultures. 
Their main purpose to create was to avoid extracting primary cell cultures 
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from tissue samples every time there is need for culture. These cell lines can 
thus be cryopreserved and used at later times. They can grow indefinitely if 
there is periodic change of media to ensure there is enough nutrient supply to 
the cells.   
Continuous cultures are formed after the cells lose the character of 
death from their genetic makeup. This phenomenon is called immortalization 
and it can occur through a natural mutation that occurs in the cells due to serial 
passaging or through induced mutation. The cell lines which did not succumb 
to the mutations are finite cell lines which would eventually be terminated 
through cell death. Such cultures have practically no application other than 
characterizations of these finite cell lines. On the other hand, continuous cell 
lines can be used for a variety of application in biopharmaceuticals. 
Continuous cultures can be cultivated in both ways: adherent and suspension. 
In the modern times, suspension cultures are predominantly used to culture 
cells. [4] 
The second important component of the mammalian cell culture is the 
cell growth media. Development of media has come a long way since the first 
time a growth medium was developed from a mixture of salts in the 1880s. 
Today, numerous formulations are available for different cell lines for 
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different levels of growth. In the early days, the serum from animal tissues or 
blood would be used as a medium of cell culturing.  
When Eagles’ invented a chemical formulation using amino acids, 
vitamins, minerals and growth factors, there was still a need to supplement 
this animal serum to sustain growth and proliferation in the cells. Early twenty 
first century obviated the use of serum in cell culture due to regulatory 
restrictions, with the creation of serum free media formulation [6]. Several 
chemically defined media are currently available for culturing mammalian 
cells for instance, CD CHO (Gibco), ExCell CD CHO (Sigma Aldrich), 
PowerCHO (Lonza), ActiPRO (GE Life Sciences) and so on.  
1.3 Monoclonal antibodies as therapeutics 
The biopharmaceutical industry has benefitted immensely over the 
last 20 years, from the recombinant DNA and hybridoma technologies. Before 
the invention of these technologies, the biomaterials necessary for medicine 
were extracted from plants and other natural resources. This leaves a very 
narrow arena to work around since we cannot create new materials or produce 
more of the existing material. Recombinant DNA technology created a 
potential for large scale production of a wide range of natural and modified 
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proteins and the hybridoma technology introduced a new class of protein 
therapeutics—the monoclonal antibodies (MAbs) [7].  
Therapeutic proteins are an alternative solution to various types of 
cancer and autoimmune disorders [8]. The number of approved biologics in 
the market increased from 84 in the year 2000 to 148 in 2003. By 2010, the 
total number of biopharmaceuticals out in the global market increased to 200. 
[9]. Monoclonal antibodies are next to vaccines in the order preference for 
development in the biopharmaceutical industries [10]. Their growth as 
therapeutic proteins is the largest among all other biomolecules used in 
medicine, as the numbers suggest that 21 mAbs were approved by the FDA in 
2008 in the United States alone [11]. This shows the global potential of mAbs 
as therapeutics of cancer and autoimmune disorders.  
Mammalian cells are the host organisms for the production of 
therapeutic proteins. There has been constant effort in the industries to 
improve the titer even by the slightest amounts possible. [12]. Several ways 
have been employed for this purpose of which cell line improvement, media 
formulation modifications, bioprocess development through improvements in 
fed-batch culture, design of new equipment and modes of bioreactor operation 
are to name a few.  
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1.4 Mammalian cell engineering 
Cell engineering of a mammalian cell is a growing field with new 
methods being developed from time to time with higher engineering 
capability and targeted gene modification potentials. One common method of 
engineering a mammalian cell is to clone the gene of interest into a 
mammalian expression vector and express the plasmid created in the cell line 
that is chosen. Cloning of a gene performs direct modification of the DNA in 
the cells which results in the expression of the gene of interest.  
Many challenges occur during the gene expression stages which 
become even more predominant as the mammalian cell chosen for expression 
ranks higher in complexity. For instance, it is relatively simple to insert and 
express a gene into an E.coli than a CHO cell. New genetic engineering 
techniques like CRISPR-Cas9, TALENS, Zinc Finger Nucleases are bringing 
simplicity in mammalian cell engineering. The most recent addition to the 
field, the cell free systems are providing platforms to produce, mRNA through 
gene expressions using the contents of the cell outside the cell membrane in a 





Mammalian cells in biopharmaceuticals are being used extensively for 
therapeutics production. The CHO cell line especially is utilized to its full 
potential to produce monoclonal antibodies. Monoclonal antibodies are the 
molecules which are used in cancer treatment and for the cure of various 
autoimmune disorders in human beings. Though CHO cells are being used to 
their full potential now, it is possible to further enhance the production and 
improve the product to raw materials cost index for mammalian cells. Use of 
media additives in cell culture and engineering mammalian cells are the ways 
to push the potential of CHO cells to produce monoclonal antibodies. The 
thesis explores these potential options and the extent of success obtained in 










Chapter 2 MATERIALS AND METHODS 
 
The work that will be described in this thesis, was performed using the 
materials and methods that have been detailed in this chapter. These protocols 
have been adopted from the companies like Thermo Fisher Scientific, New 
England Biolabs, Sigma Aldrich, Qiagen which provide support in the lab and 
thus reflect the protocol exactly given in their handbooks when the materials 
are purchased. The various cell lines used, the cell culture and molecular 
biology techniques utilized and the assays performed to obtain the final results 
of productivity or methods used for the detection are detailed in this Chapter. 
 
2.1     Cell lines 
 Three different cell lines have been used for the studies performed in 
the duration of my research work. The Hydrolysate Project used a CHO cell 
line producing IgG (CL01) which has been purchased on a 18 month contract 
from Bioceros Ltd. The Cell engineering project used two mammalian cell 
lines, namely, HEK 293T wild type (Human embryonic kidney, CL02) and 
CHO-K1 wild type (Chinese Hamster Ovary, CL03) from ECACC (European 




2.2     Cell Culture Media and Additives 
The following cell culture media and additives have been utilized for 
the culturing of the cells that have been mentioned above: 
(A) DMEM (Gibco) 
(B)          F12K Nutrient mix  
(C)          ExCell CD CHO (Sigma Aldrich) 
(D) Glutamax (Gibco) [200mM L-Glutamine] 
(E)           Poloxomer (Sigma Aldrich) 
(F)           Zeocin 
(G) Blasticidin 
(H) FBS (Fetal Bovine Serum) 
 
2.3     Cell culture Protocols 
This section will describe the general cell culture protocols that were 
used during the course of research. These protocols are generally available in 
the literatures and can be adopted depending on the cell type being used for 
research. Many mammalian cell protocols are provided by thermo fisher 





2.3.1 Cell Thaw 
Description 
Reviving cells from cryostorage is termed as cell thaw. Mammalian 
cells are fragile and the cell thaw procedure controls the way the culture 
behaves after thaw. The cryovials stored in liquid nitrogen are carefully 
removed and the contents of the vial are added to a new culture flask to grow 
the cells in a sterile environment. The general thaw protocol followed is given 
below. 
Materials 
(A) Cryovial containing frozen cells,  
(B)          Complete growth medium, pre-warmed to 37°C  
(C)          Disposable, sterile centrifuge tubes,  
(D) Water bath at 37°C, 70% ethanol  
(E)           Tissue-culture treated flasks, plates, or shake flasks for 
suspension cells 
Protocol 
1. Remove the cryovial containing the frozen cells from liquid nitrogen 
storage and immediately place it into a 37°C water bath. 
2. Thaw the cells for nearly 2 minutes by gently swirling the vial in the 37°C 
water bath until completely thawed. 
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3. Transfer the vial it into a laminar flow hood after wiping the outside of the 
vial with 70% ethanol 
4. Transfer 9mL of pre-warmed complete growth medium appropriate for 
your cell line into the centrifuge tube and add the thawed cells to the media. 
6. Centrifuge the cell suspension at approximately 1200 rpm for 7 minutes. 
After the centrifugation, check the clarity of supernatant and visibility of a 
complete pellet.  
7. Aseptically decant the supernatant without disturbing the cell pellet. 
8. Gently resuspend the cells in complete growth medium, and transfer them 
into the appropriate culture vessel and into the recommended culture 
environment. 
 
2.3.2 Cell Counting 
Description 
Once the cell thaw has revived, the cell number needs to be determined 
before sub culturing. Cell counting using hemocytometer with the principle of 
trypan blue exclusion method is a common cell counting procedure used 
which is quite economical when compared to the various automated cell 





(A) Hemocytometer (Neubauer Chamber),  
(B)          Trypan blue(0.4%),  
(C)          Cell culture sample 
 
Protocol 
1. Clean the Neubauer chamber and cover slip with alcohol.  Dry and fix 
the coverslip in position. 
2. Dilute the cell culture sample with trypan blue such that the number of 
cells that you would count be not more than 150. Vortex the sample 
thoroughly. 
3. Add 10 μL of the trypan blue/cells mixture to the hemocytometer.  Do 
not overfill. 
4. Place the chamber in the inverted microscope under a 10X objective.   
5. Use phase contrast to distinguish the cells. 
6. Count the bright cells in the four gridded squares A, B, C, D in the four 
corners of each side of the chamber.  The gridded squares are circled in 




Figure 1 Hemocytometer chamber for counting cells 
 
7. Multiply the average of the cell counts from two sides of the chamber 
by the dilution factor and divide by 400 to estimate the number of cells 
in millions per mL. This number estimated is called the Viable cell 
density and it gives the number of living cells in the culture 
8. Using trypan blue dye exclusion, the dead cells are completely stained 
blue dure to membrane permeation which I prevented in live cells. 
Count the blue dots in a similar way described in (7) which gives you 
the Dead cell density in the culture 
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9. Record the numbers on a sheet of paper and clean the chamber and 
cover slip with 70% ethanol. Dry the chamber and store it. 
 
2.3.3 Cell Passaging 
Adherent cell cultures description 
The following protocol describes a general procedure for subculturing 
adherent mammalian cells in culture. Adherent cultures require cell 
detachment from the attachment surface before sub culturing. Care should be 
taken during the cell passaging stage because any deviation to usual culture 
behavior here, reflects in the end use of the culture. 
 
Materials 
(A) Culture vessels containing your adherent cells,  
(B)          Tissue-culture treated flasks, plates or dishes,  
(C)          Complete growth medium, pre-warmed to 37°C,  
(D) Disposable, sterile 15-mL tubes,  
(E)           37°C incubator with humidified atmosphere of 5% CO2,  
(F)           Balanced salt solution such as Dulbecco’s Phosphate Buffered 
Saline (DPBS), containing no, calcium, magnesium, or phenol red,  
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(G) Dissociation reagent such as trypsin-EDTA (0.25%), without 
phenol red,  
(H) Trypan Blue and hemacytometer 
 
Protocol 
Note: All the materials in contact with the culture must be sterile. All the 
work with cells should be performed inside a Biosafety Cabinet of Biosafety 
Level 2. 
1. Clean all the surfaces coming in contact with the cells with 70% 
ethanol.  
2. Remove and discard the spent media from the culture vessel. 
3. Wash cells using Material (F), approximately 2mL for T25 flask and 
5mL for T75 flask, without disturbing the attached cells.   
Gently add material (F) to the opposite side of the vessel where the cells 
are attached to avoid disturbing the cell layer, and rock the vessel back 
and forth twice or thrice. 
Note:  The wash step removes any traces of serum, calcium, and 
magnesium that would inhibit the action of the dissociation reagent. 
4. Remove and discard the wash solution from the culture vessel 
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5. Add the pre-warmed Material (G) to the side of the flask; use enough 
reagent to cover the cell layer (approximately 0.5 mL to a T25 flask and 
2ml to a T75 flask).    
6. Gently rock the container to get complete coverage of the cell layer. 
Incubate the culture vessel at room temperature for approximately 5 
minutes. For some cell lines like CL03, the incubation should be in the 
37C incubator for 5 minutes  
7. Observe the cells under the microscope for detachment.  If cells are less 
than 90% detached, increase the incubation time a few more minutes, 
checking for dissociation every 30 seconds.  You may also tap the 
vessel to expedite cell detachment. 
8. When ≥ 90% of the cells have detached, tilt the vessel for a minimal 
length of time to allow the cells to drain.   
9. Add the one culture volume of pre-warmed complete growth medium.   
10. Disperse the medium by pipetting over the cell layer surface several 
times. 




12. Calculate the amount of inoculum necessary to start a new culture at a 
low cell density and add the calculated amount of culture to a culture 
flask containing fresh media.  
13. Place the flasks in a 37C CO2 incubator and leave until the cells reach 
about 90% confluency 
 
Suspension cultures description 
The following protocols describe general procedures for subculturing 
mammalian cells in suspension culture.  As these cells are in a suspension and 
are not attached, we do not need the step to detach the cells from the treated 
surface. These cell cultures are usually maintained in a shake flask which 
keeps agitating on a platform inside the CO2 incubator. 
 
Materials 
(A) Culture vessels containing your suspension cells,  
(B)          New culture flasks,  
(C)          Complete growth medium, pre-warmed to 37°C,  
(D) 37°C incubator with humidified atmosphere of 5% CO2 with a 
shaker platform,  




1. Take the flask out of the incubator and take a small sample from the 
culture flask using a sterile pipette.   
2. From the sample, determine the VCD and percentage viability using a 
hemocytometer,  
3. Calculate the volume of inoculum and aseptically add the appropriate 
volume of pre-warmed growth medium into the culture flask containing 
the inoculum.   
4.  Place the flask back into the incubator and measure the cell density 
after 72 to 96 hours of culturing. 
5. Run the shaker at 130 rpm for a shake flask of 125mL capacity.  
 
2.3.4 Mammalian transfection 
Description 
When we need to insert our gene of interest into a mammalian cells, we 
use transfection as the method of operation. The transfection reagent creates 
pores in the cell membrane without damaging it and the plasmid containing 
our gene of interest is then carried into the cell using the chemical molecules 





(A) Lipofectamine 3000 
(B) 6 well plates  
(C) DNA for transfecting (2.5ug per transfection) 
(D) OptiMEM 
(E) CO2 incubator with humidity 
(F) Biosafety Cabinet 
(G) 1.5mL Eppendorf tubes 
Protocol 
1. Seed the cells into a 6 well plate and grow until the cells reach 70-90% 
confluence. 
2. Once the cells reach confluence, remove the culture media and wash 
the cells with PBS without disturbing the attached cells 
3. Add 1.75mL of fresh prewarmed OptiMEM media and prepare the 
transfecting mixture in two different tubes 
4. To the first tube labeled ‘Tube 1’, add 2.5ug of DNA, 5uL of Reagent 
P3000 (a part of the Lipofectamine 3000 kit) and 125uL of OptiMEM 
media in this order. 
5. To the second tube labeled ‘Tube 2’, add 125uL of OptiMEM media 
and then add 5uL of reagent Lipofectamine 3000. 
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6. Add Tube 2 to Tube 1 and wait for 5 minutes. Do not disturb the tube 
or pipette it in this time.  
7. After 5 minutes, add the contents present in Tube 1 dropwise into the 
culture well.  
8. Transfer the well plate into the CO2 incubator without disturbing it 
9. After 24 hours, add 500uL of fresh culture media into the well to give 
enough nutrients for the cells to sustain in the culture. 
10. The cells should be harvested after 72 hours of culturing either using 
trypsin or lysed using cell dissociation solution (either RIPA buffer or 
Cell lysis solution). 
11. After harvesting the cells, the samples should be centrifuged at 
13000rpm for 10 minutes and the supernatant can be stored in -80C as 
the cell lysate containing the protein expressed through transfection.  
 
2.3.5 Sample preparation for proteomics 
Once the cell culture experiment is performed, if we have to perform a 
proteomics analysis, the samples should be prepared before handing it to the 
Mass spectrometry experts for analysis. The following protocol should be 
followed to prepare the cells and later analyze them before sending the sample 
for proteomics.  
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Preparing cell pellets:  
Materials 
(A) ice cold PBS,  
(B)          Cell culture samples 
(C)          pipette, conical tubes, eppendorf tubes,  
(D) bucket of ice,  
(E)           bucket of dry ice 
Protocol 
1. Collect cell culture 
2. Spin down pellet at 4C for 10min, 1200RPM 
3. Remove media and resuspend in PBS 
4. Divide 2-3e6cells into 1.5mL eppendorf tubes (1mL per tube) 
5. Centrifuge eppendorf tubes at 4C for 5min, 5000RPM 
6. Remove PBS and resuspend in PBS 
7. Centrifuge eppendorf tubes at 4C for 5min, 5000RPM 
8. Remove PBS and freeze on dry ice 
9. Store frozen pellets at -80C 
Protein digestion:  
Materials  
(A) Frozen cell pellet,  
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(B)          2% SDS, TEABC, PMSF, EDTA, Iodoacetamide, TCEP,  
(C)          BCA assay kit, 9M urea, spin filters 10kDa, ammonium 
bicarbonate, speed-vac, hydroxylamine, centrifuge, pure water,  bucket 
of ice, TMT 6plex kit, triethyl ammonium bicarbonate (90360 Sigma), 
glacial acetic acid (100%, A38-500 Fisher) 
Protocol 
1) Prepare 100mM PMSF aliquots dissolved in isopropanol, can store at -
20C. PMSF (phenylmethanesulfonylfluoride).  
2) Use cell pellet frozen at -80C. Prepare 2 % SDS and then take out how 
much you need and measure pH (use ultrapure water).  
3) Add 0.1 mM PMSF and 1 mM EDTA to final concentration (after you 
added PMSF in it, you should put it on ice but the SDS can get crystallized if 
it waits very long in ice. So be careful, either prepare it in small amounts or 
always check the tube and vortex it or bring it to room temperature.) 
PMSF and EDTA was added to added the SDS before the cells were added in 
order to have a large volume  (easier to pipette).  
5) The lysates are denatured in lysis solution. Sonicate three times as 60 
seconds sonicate and 90 seconds pause on ice (the sample should not get 
heated while sonication). Do the sonication on ice (Sonication for one minute 
then rest on ice while other sample was sonicated) Set sonicator to 40% so it 
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does spray as much. Have an ethanol napkin to dry off the sonicator between 
samples 
6) SDS can get crystallized so be careful on the sample. If it is crystallized, 
vortex it well after sonication to get a good sample for BCA.  
7) The protein concentration is measured with BCA assay 
BCA Assay 
This assay measures the total protein content in the sample. This is a 
colorimetric assay and needs to be performed at specific time points without 
delay. The BCA assay comes as a kit and the instruction to run the assay are 
given in the handout provided. 
Protocol 
1. Mix Reagent A and Reagent B in a 1:50 ratio and add 200uL of this 
mixture to each wells to be used in a 96 well non-treated plate 
2. Add 25uL of the standards A through I  (Prepared in advance from the 
BSA standard provided with the kit) in triplicates into the wells already 
containing 200uL of the reagent 
3. In a similar fashion add, the protein sample you want to analyze at your 
desired dilution. Note: Vortex all the samples and standards before 
adding to the wells 
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4. Incubate the plate at 37C for 30 minutes to 1 hour and analyze the plate 
using a plate reader at 290nm 
 
2.3.6 ELISA for IgG Quantification 
Materials 
(A) DPBS (Dulbecco’s Phosphate Buffered Saline) ready to use 
(Invitrogen Catno. 14190-094) 
(B)     Tween-20 
(C)     Pierce Protein-free block  
(D) Bovine serum albumin (BSA) 
(E) Capture antibody: Mouse anti Human IgG Fab specific, 1.5 mg/ml 
(Jackson 209 005 097, store at 4°C) 
(F)      Detection antibody: Goat anti human IgG-HRP Fc specific, 0.8 
mg/ml (Jackson 109 035 098, store at 4°C) 
(G)      ABTS (=2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic 
acid)) single solution (ZYMED Cat no. 00-2024, store at 4°C) 
(H) IgG standard: Purified human IgG, 5 mg/ml (Zymed Catno. 02-
7102) (store at -18°C) 
(I) Coating buffer: 5 μg Capture antibody/ ml in DPBS (prepare fresh 
daily) pipette 10μl Capture antibody in 30ml DPBS 
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(J)      Wash buffer: 0.05% Tween-20 in DPBS (prepare fresh daily) 
pipette 0.5ml Tween-20 in a mixture of 500ml DPBS and 500ml 
demineralised water 
(K)      Stock Protein solution: 6% (w/v) BSA in DPBS dissolve 3 
grams BSA in 50ml DPBS, 
(L) Blocking buffer: 2% BSA in wash buffer (prepare daily) dilute 30ml 
stock EM-7 with 60ml wash buffer 
(M)      Diluents buffer: 0.33% BSA in wash buffer (prepare daily) 
dilute 20ml blocking buffer with 100ml wash buffer 
(N) Detection buffer: Detection antibody 1:6500 in diluents buffer 
Pipette 4μl detection antibody in 26ml diluents buffer Dilute 
directly before use. 
(O) Stop solution: 0.1 M citrate Dissolve 5.259 gram sodium citrate 
in 250ml MilliQ or sterile water, (store at 4°C.) 
 
Protocol 
1. Coating the Plates: Add 100 μl of the coating buffer to every well of 
the 96 wells plate. Incubate the plate overnight (at least 12 hours) at 
4°C, covered with aluminum sealing tape. 
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2. Preparation of calibration curve: Pipette 10 μl IgG standard in a 50 ml 
flask and dilute with diluents buffer to 50 ml (standard solution A). 
Concentration: 1000 ng IgG/ml. 
     Dilute standards in polypropylene tubes as follows: 
 
Table 1: Standard preparation for ELISA 
Sno. Standard 
solution 


















































1. Wash the coated plate 3 times with 200μl wash buffer in the plate 
washer 
2. Dry the plate by tapping it gently on a tissue, lied flat on the bench 
3. Pipette 200 μl blocking buffer into each well 
4. Incubate plate, covered with aluminum sealing tape, for 60 minutes at 
room temperature. 
5. Wash the plate 3 times with 200μl wash buffer in the plate washer 
6. Dry the plate by tapping it gently on a tissue 
7. Add the sample and the standard in the scheme that has been 
determined on the plate.  
8. Incubate plate, covered with aluminum sealing tape, during 60 minutes 
at 37°C on the shaker at 350 rpm. 
9. Wash the plate 3 times with 200μl wash buffer in the plate washer 
10. Dry the plate by tapping it gently on a tissue 
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11. Add 100μl detection buffer/well 
12. Incubate plate, covered with aluminum sealing tape, during 60 minutes 
at 37°C on the shaker at 350 rpm 
13. Wash the plate 3 times with 200μl wash buffer in the plate washer 
14. Dry the plate by tapping it gently on a tissue 
15. Clean, if necessary, the underside of the plate 
16. Pipette 100μl ABTS into each well 
17. Incubate for 6 minutes 
18. Pipette 100μl stop solution to each well 
19. Measure the extinction at 410 nm (=E410), within 10 minutes after 
stopping the reaction 
 
2.4      Molecular Biology Protocols 
In Chapter 4, molecular cloning has been an integral part of the 
research. Genes have to be cloned into a mammalian expression vector for 







2.4.1   PCR Cloning 
Adding a gene to a plasmid is called cloning. When this cloning insert 
is obtained through a Polymerase chain reaction, it is termed as PCR cloning. 
There are several steps involved in this process are: 
(A) Designing primers for the gene of interest and performing a PCR 
to obtain the gene out of the genome or the plasmid is the first step in cloning. 
PCR reaction is performed in a thermos cycler by shifting the temperatures at 
the end of each cycle to perform the reaction. The reagents that were used for 
PCR are from New England Biolabs. The table below gives the protocol used 
to perform this step: 
1. Add the components given in the table into an Eppendorf tube and 
mix them well 
2. Place all the component of ice at all times along with the master 
mix prepared. 
3. Add 25uL of the master mix to each PCR tube and start the 
thermocycler with the settings recommended and the annealing 
temperature set. 
4. After the cycle ends, place the PCR tubes on ice for immediate use 




                Table 2: Phusion Polymerase master mix recipe 




 To 50uL 
5x Phusion HF or 
GC buffer 
1X 10uL 







Template DNA <250ng Variable 
Phusion DNA 
Polymerase 




(B)    Gel Electrophoresis and PCR purification:  
Once the PCR reaction is completed, the sample needs to be tested to 
check if the insert has been amplified or not. For this purpose, we perform gel 
electrophoresis with 0.1% agarose gel as follows: 
1. Add 0.4g of ultrapure agarose to 40mL of 1X TAE buffer and boil 
the solution. 
2. After the solution becomes lukewarm add 4uL of Ethidium 
bromide, pour the gel into the casting chamber and add the comb.  
3. Once the gel sets, transfer it to the electrophoresis chamber and load 
the DNA ladder and the sample into the wells. 
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4. Run the gel at a constant voltage of 70 to 100 volts for 1 hour, 
ensuring that the DNA doesn’t run off into the buffer 
5.  Once the run is completed, visualize the gel under UV light to see 
the DNA bands. 
Once the DNA of interest is detected on the gel, it can either be 
extracted from the PCR product using gel extraction kit or PCR purification 
kit from Qiagen. The protocol is given along with the kit which can be 
followed to perform this step. In general PCR purification gives higher 
quantities of DNA when compared to gel extraction.   
(C) Restriction digestion and Ligation 
After the insert has been purified from the PCR mixture, the insert and 
the plasmid needs to be digested using restriction enzyme for creating a spot 
on the plasmid for the insert to attach. Digesting the DNA is immediately 
followed by ligation and the plasmid is ready for transformation.  
 
2.4.2   Bacterial Transformation 
The plasmid which contains the insert needs to be inserted into a 
bacterial organism for replication purpose. This step is termed as bacterial 
transformation. The organism chosen for transformation is an E.coli which is 
at its peak of production once thawed. Such cells are known as competent 
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cells. The protocol to transform bacteria to copy our plasmid is adopted from 
Addgene and is given below: 
1. Take competent cells out of -80°C freezer and thaw them on ice for 30 
minutes. 
2. Prepare LB agar plates with antibiotics resistance and leave them at room 
temperature to set under sterile conditions (flame on) 
3. Take 1-5uL of DNA (containing 10pg to 100ng of DNA) and add to 25uL 
of competent cells and place the mixture back on ice for 30 minutes 
4. Place the cells containing the DNA in a water bath at 42C for 45 to 60 
seconds and immediately transfer the tube to ice and incubate for 2 minutes 
5. Add 500uL of SOC media (without antibiotics) and incubate the tube at 
37C for 45 minutes. 
6. Pour the contents of the tube on to the agar plate and spread them using a 
cell spreader 
7. Incubate the plates for 12 to 16 hours and check for colonies.  
8. Once there are colonies formed, pick a few colonies to grow the E.coli in 
liquid LB medium. 
9. After 12 hours, create glycerol stocks with the culture and extract the 




2.2.1 Western Blotting 
Western blotting was performed on cell lysates in the research 
described in Chapter 4. Western botting is a two step procedure. After 
performing BCA to know the total protein concentration in the cell lysate 
sample, they are used to run an SDS-PAGE gel which is the first step. Later 
the gel contents are transferred onto a PVDF membrane to detect if the gene 
inserted has been expressed or not. 
(A) SDS-PAGE 
Gel electrophoresis using a poly acrylamide gel is a common 
technique used to separate a mixture of proteins based on their molecular 
weights. The protocol used to perform this step is given below: 
1. The samples to be loaded are prepared using lysate samples, PBS and 4X 
loading dye (prepared from lamellae buffer) 
2. Samples are denatured using heat at 95C for 5 mins to linearize the 
proteins for the gel run 
3. Load the samples and the ladder on to the gel and run the gel at 70 volts 
for 15 minutes until the samples get out of the well and later bump up the 
voltage to 100V for resolving the samples in the gel. 




(B)          Blotting 
After SDS-PAGE, the gel contents have to be transferred to PVDF 
membrane and later the membrane needs to be blocked. The blocking step is 
followed by treating with the primary and secondary antibody. After the 
secondary antibody incubation step is completed, the membrane can be 
visualized for the protein of interest. These activities can be performed 
through the following steps: 
1. Assemble the transfer cassette by placing in the transfer buffer in this 
order: Cathode(Black)  Sponge pads  filter paper  gel  
membrane  filter paper  sponge pads  Anode (white) 
2. Run the transfer process at 100V for one hour using cold transfer buffer 
and an ice pack inside. 
3. Once the transfer process is completed, block the membrane for one hour 
using 5% milk prepared using Blotting grade blocker from BioRad 
4. Incubate the membrane with primary antibody overnight at 4C. 
5. If the primary antibody is HRP conjugated, the membrane can be taken 
for detected at this stage. Otherwise, the membrane should be incubated 
with a secondary antibody conjugated with HRP for an hour to enable 
detection. Use chemiluminescence to detect the protein on the membrane 
with the help of Pierce kit.  
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Chapter 3 HYDROLYSATES IN MAMMALIAN CELL CULTURE 
MEDIA 
 
3.1 Introduction  
Cell culture media provides the necessary nutrients for the cells to 
grow. It is a mixture of substrates like glucose, glutamine, and other amino 
acids together with other components important for the growth of mammalian 
cell cultures like vitamins, minerals and certain growth factors. The culturing 
of mammalian cells was done in early 1900s in naturally available serum from 
blood of different mammals. Such media are comprised of a balanced salt 
solution with natural growth promoting elements like serum, body fluids and 
exudates, and extracts of tissues and organs. Since the composition of these 
natural elements is not known, we introduce a lot of variability into the cell 
cultures. Such inconsistent processes are not suitable for producing large scale 
biomolecules since the bioprocess is not controlled by external factors. It is 
also difficult to track the metabolism of cells growing with serum due to 
unknown components though they are cultures in controlled conditions.  
Eagle in 1950s made the most significant advancement in the nutrient 
requirement of cell cultures. He could create a chemically assembled medium 
combining amino acids, vitamins, cofactors and add serum to it to propagate 
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cell cultures. Even though a chemically defined media was invented by Eagle 
and group, it still used serum to grow the cultures [6]. Serum contains 
important components necessary for the growth of cell culture like proteins, 
growth factors, lipids and other trace elements. Use of serum to produce 
biologics has a major regulatory and economic concern. When serum is used 
to culture cells, there might be a possibility of bacterial, or viral contamination 
or a presence of mycoplasma which could not be eliminated to a 100% after 
multiple steps of purification. Also, Food & Drug Administration (FDA) will 
not approve any drug created in a process which uses animal components in 
its process [13]. This was a major drawback of the cell culture media until the 
development of serum free media which is fully chemically defined media 
without using any animal component in it. Serum-free media reduced the 
downstream processing cost for the industry and opened paths to design media 
with millions of different formulations. But the strength provided by the 
serum was still lacking in the cell cultures.  
Strategies to replace this serum deficiency with another new component 
or nutrient enhancement has led to the introduction of hydrolysates into the 
cell culture media. Hydrolysates are derived from plant proteins like cotton, 
soy, wheat, rapeseed and so on. These hydrolysates not only were known to 
improve the growth by also were able to increase the productivity of the cell 
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cultures. With this unique feature, the era of serum-free media turned towards 
Hydrolysates for relief [14]. The hydrolysate supplementation to a serum free 
formulation enhanced the productivity of the cell lines similar to the case with 
serum containing media [15]. As soon as the utility of the Hydrolysates was 
discovered, there were various studies, proving their ability to improve the 
cell culture performance and different sources of hydrolysates were compared 
to find a winner among the troop, wheat hydrolysate giving 56% increase in 
productivity [16]. Even though this is a known fact today, the mode of action 
of the hydrolysates is yet to be explored. Several -omics tools exist to guide 
us through the metabolism that the hydrolysates undergo inside a mammalian 
cell. This chapter describes one such attempt to know the cause of the action. 
 
3.2     Aim 
Cell culture media composition can significantly influence the 
phenotype of a cell line. The influence of a component on the cell culture 
performance varies even with the chemical formula it is in. Media components 
can affect recombinant protein production yields, growth, and product quality. 
Optimal concentration of all the media components is a necessary condition 
for running a cell culture process. It is thus important to control media 
formulations in order to develop a robust process. Hydrolysates has been 
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known to improve the cell culture performance for a decade now. Plant protein 
hydrolysates are a replacement to animal serum in cell culture media. They 
have a concoction of nutrients that would potentially boost the cell culture 
performance. Commercial media providers have been using several kinds of 
hydrolysates to media. The effect of hydrolysates on the culture performance 
is also dependent on the cell line available. An IgG producing cell line was 
provided by Friesland Campina through Bioceros Ltd to test if there is an 
improvement in productivity in the CHO cell line due to hydrolysate 
supplementation. All the hydrolysate lots provided were produced by 
Friesland Campina from soy and cottonseed. 
Every lot of the hydrolysate do not behave in the same way with the 
cell line available. The effect of hydrolysate might also vary with the type of 
cell line used. For this reason, various lots of hydrolysates have been 
manufactured by the Friesland Campina and these lots will be evaluated for 
the cell culture performance and final IgG productivity. While the cell culture 
performance will be evaluated using cell viability and viable cell density 
measurements, the antibody productivity will be measured using ELISA. 
Although the composition of the cottonseed hydrolysate and soy hydrolysate 
is known to Friesland Campina, the component(s) which enhance 
productivity, cell growth, and product quality are not defined precisely. 
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Therefore, the goal will be to verify the effects of hydrolysate supplementation 
primarily on recombinant protein productivity. Specifically, the effect of 
cottonseed hydrolysate during exponential and stationary phases will be 
distinguished.  A secondary goal will be to establish any effects of the 
hydrolysate on cell growth.  The intermediate aims will use transcriptomics 
and metabolomics to elucidate the mechanism of action of 
hydrolysates.  Overall, the project will increase understanding of how 
hydrolysate supplementation affects bioprocess parameters.  This will be 
accomplished using transcriptomics and metabolic flux analysis to delve 
deeper into cell culture metabolism the result of which will be worked out in 
the future studies. 
The project aims to evaluate how hydrolysate supplementation affects 
the recombinant protein production yields and growth of a cell line, 
respectively. The cells will be supplemented with hydrolysates which have 
been manufactured from cottonseed and soybean at Friesland Campina. The 
different lots of hydrolysates behave in a different manner and influence the 
cell culture in a different way. The effect of different lots and types of 
hydrolysates will be evaluated for the given cell line producing IgG as the 
monoclonal antibody product. Cell growth will be monitored daily by 
hemocytometer using trypan blue dye exclusion method. The recombinant 
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protein production will be measured by an ELISA assay. We will look for 
differences in product yields as a result of cottonseed hydrolysate, soy 
hydrolysate, or no supplementation during both exponential and stationary 
phases. It is expected that cottonseed hydrolysate supplementation boosts the 
mammalian cell growth rate with increased recombinant protein production 
in comparison to soy hydrolysate supplemented culture media and media with 
no supplementation. The further section will describe the details of the 
experiment and the results and discussion 
 
3.3     Culturing cells for the experiment 
3.3.1 Cell thaw 
Six vials were sent to JHU in April 2016. Cells were revived from liquid 
nitrogen (-196°C) using a cell thaw protocol used for mammalian cell cultures 
(Section 2.3.1). The cell media to during thawing cells is ExCell CD CHO 
media supplemented with 0.4% of Soy Hydrolysate. Take 48ml of ExCell CD 
CHO and add 1ml of 200 mM solution of L-Glutamine. Then add 1ml of 
Poloxomer 188 to the mixture. Then weigh 0.4% of soy hydrolysate which 
would be nearly 200mg and dissolve it in the culture media prepared above. 
This will darken the color of the media to golden.  
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Once the soy hydrolysate dissolves completely, filter the solution using 
a 0.22micron syringe filter to use it in a sterile manner. This thaw media 
should be freshly prepared for every cell thaw. The culture media after the 
addition of soy hydrolysate cannot be used after 96 hours. In a 15ml falcon 
tube, add 9mL of the culture media prepared. Thaw the cell vial in a 37°C 
water bath and add the contents of the vial to the falcon tube containing 9ml 
of culture media. Centrifuge the tube containing the contents of the vial at 
1200 rpm for 5 to 7 minutes to remove the DMSO added to the cells while 
freezing. Discard the supernatant and resuspend the pelleted cells at the 
bottom of the falcon tube in 10ml of fresh culture media. Add this resuspended 
culture into a new ultra low attachment tissue culture flask and top it up with 
5ml culture media to start the initial cell culture at 15mL.  
Take the initial cell count and viability measurements. The cell density 
was observed to be around 0.2 million cells/mL and the cell viability was 
nearly a 100%. After 24 hours, it was observed that the cell culture viability 
has dropped to less than 40% and after 48 hours it further dropped to 0%. This 
was the first challenge encountered and had to be resolved in order to continue 
the project further. Several alternate procedures were tried to revive the cells.  
Alternate procedure 1: Another vial was thawed and after 24 hours, the 
cell culture was centrifuged to replace the old culture media with new one. 
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This change in the thaw protocol was made through the hypothesis that, the 
cells are being exposed to some harmful contents in the culture media and 
after 24 hours all the necessary nutrients of the media were exhausted and 
replacement would provide extra nutrients to grow. On the contrary, the cell 
viability reduced further after 48 hours due to centrifugation and further 
resuspension of cells, some cells have been lost further reducing the cell 
density. This ruled out of hypothesis that the nutrients in the media were 
exhausted and we moved on to the next alternative. 
Alternate protocol 2: After vial thaw, the culture in the tissue flask was 
decided to be moved to the shake flask before the culture viability hits 50%. 
This would give the culture enough cells to expand in a shake flask condition. 
We observed in the previous vial thaws that the culture viability dropped to 
almost 50% after 24 hours. Thus, we have decided to move the culture to a 
new shake flask and top it up with 10mL of cell culture media with no soy 
hydrolysate supplementation. This method gave less cells to begin with but 
the culture flask took 10 days to grow to a cell density greater than 1 million 
cells/mL. Once the culture was transferred to a shake flask after 24 hours, the 
cell density was less than 0.05million cells/mL. The culture media was 
replaced every three to four days to ensure that the nutrients like glutamine 
have not been depleted or degraded since the culture temperature is 37°C.  
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The cell counts and viability were monitored every three days to have 
enough time for the cells to grow. The doubling time was greater than 40 hours 
in the first few days and then by the end of 10 days the doubling time came 
up to 24 hours. The bank not being in good condition was the reason for our 
problems, not allowing us to revive the cells successfully. The cell thaw 
procedure was finally revised for these cells. The subsequent sections describe 
the maintenance of seed train and the details of the experiments performed to 
test the effect of hydrolysates on cell culture performance in CHO cells. 
 
3.3.3 Subculture 
After the cells fully recovered from the vial thaw, they were allowed to 
grow to a cell density of greater than 1 million cells/mL and then sub cultured 
at a density of 0.2 million cells/mL. Take 30mL of culture media containing 
0.6mL of L-Glutamine and 0.6mL of Poloxomer 188 in a baffled shake flask. 
Based on the cell count of the old culture flask, calculate the volume of culture 
necessary to seed the new flask with 0.2million cells/mL. Remove the amount 
of media calculated from the new flask and add the same amount of old culture 
into the new flask.  
Label the flask and place it on a shaker platform in an incubator shaking 
at 130 rpm and the conditions of the incubator are 5% CO2 and 37C. Wait for 
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three days until the cells grow to a cell density greater than 1 million cells/mL. 
In case the viability of the culture is low, the culture cannot be used for future 
experimentation. One way to increase the viability in such cultures, if the 
value is below 50%, is to replace the old culture media and the dead cells 
along with the debris by centrifugation. The centrifugation process at 1200 
rpm for 5 mins would settle only the cells and not the debris and lysates of the 
dead cells which are present in the supernatant. The proteases in the cell debris 
and lysate would stop damaging the healthy cells and fresh media would 
provide new nutrients to the cell culture for growth and cell division.  
 
3.4     Cell culture experiments 
3.4.1 Experiment 1 
To determine the effect of hydrolysates on the CHO cells provided by 
Friesland Campina, a batch mode of operation for the cell culture should be 
performed and the growth characteristics of the cells should be observed. As 
a preliminary study to check if there is a difference between the growth of cell 
in normal media, soy and cotton hydrolysate supplemented media, a test 
experiment was performed with three flasks one for each condition. This 
experiment would give us more information on the growth profile of the CHO 
cells provided to us and confirm to us that all the materials provided are 
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behaving in a way in which they are intended to. For example, we have to 
check that the media is not killing the cells and is working well to let the CHO 
cells grow.  
We also need to check whether the optimal conditions for growth of the 
cells is 5% CO2, 130 rpm and 37C. There should also be a prior knowledge 
of the day to day cell growth before we perform the actual experiment with 
for our end goal. We should have the information of when the cells would 
crash and when the nutrients provided at the beginning of the culture in a batch 
process would be exhausted. For these purposes, the first experiment was 
planned and executed with three flasks one for each condition of media 
additive.  
Table 3: Details of the plan of Experiment 1 
Flask No. Condition Type of Additive Lot No. 
1 Control No Additive N/A 
2 Hydrolysate 1 0.4% of Soy Hydrolysate SE50MAU 




To start the cultures, we have to follow the protocol described in the 
following. After determining the volume of inoculum needed to start the batch 
process at a seeding density of 0.2 million cells/mL, the old media should be 
replaced with the culture media containing the additive that the flask needs to 
start with by centrifugation and further resuspension. This would ensure that 
there is no media carry over from the passage flask and the concentration of 
hydrolysate in the media is indeed 0.4% and not less. This concentration of 
hydrolysate was prescribed by the collaborator company. Increasing the 
concentration would increase the osmolality in the culture leading to damage 
to the cells. As the hydrolysate is a bolus of nutrients comprising of sugars 
and proteins, the diversion from the optimal concentration would increase the 
variability in the expected result. (*See FR thesis) 
Cell culture samples were collected daily for cell growth analysis using 
a hemocytometer and the samples of the later days nearing to the end of 
culture (day 5 to day 8) were centrifuged and the supernatant was stored to 
perform the titer analysis using ELISA and YSI analysis for Glucose and 






Cell culture performance results 
The cell culture was harvested on Day 11 when the viabilities of all the 
flasks was below 50%. The criteria for harvesting cells is that the culture 
should have viability less than 50%. Once this criterion is met, the culture is 
transferred into a 50mL falcon tube and centrifuged at 3000 rpm for 10 mins 
to pellet down all the cells and have just the media in the supernatant. The 
supernatant should be stored in -80°C for preventing it from degradation. All 
the samples collected during the cell culture should also be stored in -80°C so 
that there is no degradation of proteins in the samples. The number of freeze-
thaw cycles should be reduced to minimize any damage to the samples due to 
temperature shock.  
As to the results of the experiment, the cell culture performed well with 
the provided media ExCell CD CHO fusion. The culture was started at a cell 
density of 0.2 million cells/mL. There was exponential phase for the first five 
days and then the culture hit stationary phase for the next three days then the 
culture progressed to death phase. This was the trend with all the variants of 
the cell culture in this experiment. The distinction between the three 
conditions that was supposed to appear in the cell growth is shown in the cell 
growth plots.  
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When we see the VCD plot, we can see that Flask 1 has a slower growth 
when compared to the other two flasks. This is due to the absence of 
hydrolysate in the media. The presence of 0.4% of hydrolysate in the culture 
media is seen to have an effect on the cell count. We should look at the 
viability plot and observe that after the culture hits the stationary phase, the 
viability of flask 1 drops gradually whereas the other two flasks crash all at 
once. This observation is a clear distinction between the condition where 




Figure 2 Viable cell density (Top) and Viability (Bottom) of the culture in 
Experiment 1 
 
The peak cell density which is the maximum cell density attained in a 
cell culture process for the flasks containing hydrolysates is clearly higher 





3.4.2 Experiment 2  
Once there was a level of confidence with the cell culture batch process, 
the second experiment was planned with more conditions. The aim of the 
second experiment was to test three of the five lots of cotton hydrolysates 
manufactured by the collaborator company in 2016. These lots that were 
selected for this are 100NTCR, 100PCHO and 100P1HW for cotton 
hydrolysate. The three cotton lots were selected based on the fact that they 
were the most recent ones to be manufactured by the company.  
This time of manufacture is an important factor because as the days of 
manufacture increases, there is a fairly higher chance for the hydrolysates to 
absorb moisture and become clumpy. When the hydrolysate powder absorbs 
moisture, it can no longer be used for the experiment. Thus, the hydrolysate 
powder should be kept away in a dry place and out of light. The experiment 2 
was planned with 5 different conditions in a total of 9 cell culture flasks. The 
different hydrolysates were run in duplicates. The scheme of the experiment 








Table 4 Details of the plan of Experiment 2 
Flask No. Condition Type of Additive Lot No. 
1 Control No Additive N/A 
2 Hydrolysate 1 0.4% of Soy Hydrolysate SE50MAU 
3 Hydrolysate 1 0.4% of Soy Hydrolysate SE50MAU 
4 Hydrolysate 2 0.4% of Cotton Hydrolysate 100NTCR 
5 Hydrolysate 2 0.4% of Cotton Hydrolysate 100NTCR 
6 Hydrolysate 3 0.4% of Cotton Hydrolysate 100PCHO 
7 Hydrolysate 3 0.4% of Cotton Hydrolysate 100PCHO 
8 Hydrolysate 4 0.4% of Cotton Hydrolysate 100P1HW 
9 Hydrolysate 4 0.4% of Cotton Hydrolysate 100P1HW 





Cell culture samples (of 200uL volume) were collected daily for cell 
growth analysis using a hemocytometer and the samples were centrifuged and 
the supernatant was stored to perform the titer analysis using ELISA and YSI 
analysis for Glucose and Lactate metabolism data. 
 
Cell culture performance results 
The second experiment was aimed at looking also at the lot variability 
between the cotton hydrolysate lots that were manufactured in 2016 and 
provided to is by the collaborator company. The cell culture plots of this 
experiment are given below. From the VCD plot we can see that the media 
without hydrolysate supplementation clearly has much lower cell densities 
compared to the other samples. We have seen a reduction in cell densities for 
all the flasks after day 0. When we inoculate the flaks at 0.2million cells/mL, 
the count on day 1 reduces to around 0.15million cells/mL and then the cell 
growth picks up. This slowing of growth is reflected as reduction in viability 
too on Day 1. Probing into this issue further revealed the reason for this 
observation.  
The protocol provided by the company mentions that we need to 
centrifuge the inoculum to remove the old media so that exact amounts of 
hydrolysate is reflected in the culture. Centrifugation is a rough procedure 
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which is stressing the cells. Moving the cells into a new media which contains 
hydrolysate is not a reason for this viability crash is not a reason since the cells 
in the control flask have also shown a reduction in viability. Adding to this, 
the initial cell density is only 0.2million cells/mL. This is a low cell density 
to start with and when the viability drops at this cell density, the cells take 
some time to recover.  
Owing to these reasons, the viability drop is justified. It is in line with 
this observation that, the cells culture containing hydrolysate showed faster 
recoveries when compared to the control flask. This shows us that the 
hydrolysates are in fact providing a boost of nutrients and extra factors 
necessary for growth for the cells in the culture.  
 
 




We have tested three different lots of cotton hydrolysates in this 
experiment run. All the three cotton hydrolysate lots performed better than 
control flask in terms of cell density and cell viability. The peak cell density 
of the cotton lots were more than 100% higher than that of the control flasks. 
As this observation served half the purpose of our experiment, when the cotton 
lots were compared to the soy hydrolysate lot which also performed better 
than the control flask, there were some interesting observations made. 
 
 






When we look at the lactate plot, an interesting observation is that the 
soy hydrolysate flask starts with almost double the amount of lactate when 
compared to the control and the cotton hydrolysate lots. The lactate 
consumption profile is still the same with an offset of the 2times the value that 
was found in the cotton hydrolysate and control samples. This increased 
amount of lactate had to be made sure that it wasn’t interfering with the cell 
culture performance whatsoever.  
 





Figure 10: Lactate production rate (picogram/cell.day) in Experiment 2 
 
For this reason, a pH experiment was planned if there is any variation 
in pH among all the different variants. Among the three lots of cotton 
hydrolysate, PCHO has performed the best in improving the cell growth in the 
common culture conditions. The next experiment would prepare samples for 
the proteomics analysis. The integral viable cell density (IVCD) plot of the 
current experiment are given below. This value helps in the evaluation of 
consumption and production rates of different substrates and metabolites 





Figure 11:Integral Viable cell density (million cells.day/mL)for Experiment2 
 
3.4.3  Experiment 3 
After checking the results of the previous two experiments, the next 
experiment had to give samples for proteomics analysis. The explanation will 
be described in the following sections. After two confident runs with the 
hydrolysates, the next experiment was also targeted to perform the pH 
experiments. For proteomics analysis, two samples were to be collected from 
each flask and two different time points - one sample at mid exponential and 
the other sample at early stationary phase. These two data points for 
proteomics would give us more information about the reason why 
hydrolysates influence the culture in the way it does. For this purpose, a cell 
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sample containing 1 million cells needed to be collected. So, we first take a 
sample for cell counting from the flask and then take another sample such that 
the total number of cells comes up to 1 million. Later these cells need to be 
prepared to run the proteomics analysis and handed over to the facility at 
Hopkins. 
Keeping this aim in mind, a plan was made to run five flasks in each 
condition. Thus, in total there were 15 flasks, 5 flasks each for one condition. 
Two flasks out of the five were used to collect samples for proteomics, two 
flasks out of the remaining three were used to collect the samples for 
transcriptomics and the remaining one flask was used to study the variations 
in pH during the course of the experiment, particularly during the days when 
the proteomics samples were decided to be collected. Out of the five cotton 
hydrolysate lots tested, one cotton hydrolysate lot was selected for this 
experiment which was NTCR because, this cotton hydrolysate lot provided 
the same growth affect as soy hydrolysate but increased the productivity of 
the cells when compared to soy and control. Also, there was more data 
available for this lot from the first and the second experiment. The scheme of 




Table 5: Experimental plan for Experiment 3 
Condition No. No. of Flasks Condition Lot No. 
1 5 Control N/A 
2 5 Soy Hydrolysate SE50MAU 
3 5 Cotton Hydrolysate 100NTCR 
  
Cell culture performance results 
This experiment’s results were comparable to the previous experiments 
on terms of cell growth. NTCR performed similar to Soy hydrolysate and bpth 
were better than the control flask. The samples were collected for proteomics 
analysis at day 4 and day 6 as recommended by the collaborators based on the 
previous experiment growth curves. The problem with this experiment was 
twofold because of which this was considered to be a faulty experiment and 
the samples were not taken forward for proteomics analysis. One reason was 
that, what was assumed to be the early stationary phase of the experiment, 
turned out to be the late exponential phase. Also, it was later decided that the 
cotton hydrolysate sample to be chosen for proteomics analysis should 
perform better than soy hydrolysate and not similar to it in terms of cell 
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density. For these two reasons, this experiment was not considered for 
proteomics analysis. Nevertheless, this experiment gave us valuable 
information on the pH of the culture at four different time points of the cell 
culture, i.e., Day 0, day 4, day 6, and day 8(harvest). The pH value was pretty 
much the same for all the flasks with minor .1 to .2 units difference which 
could be considered as the instrument error. 
 
 
Figure 12: Viable cell density (million cells/mL) for Experiment 2 
 
3.4.4 Experiment 4 
The results in the previous experiment could not give good samples for 
proteomics due to sampling at insignificant time points. Also, the cotton 
hydrolysate lot used performed similar to the soy hydrolysate which was 
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assumed to not show any differences in the proteomics analysis. For these 
reasons, the scheme of experiment 3 was decided to be repeated but before 
that, we had to check for the lot variability of various cotton lots and select 
the one that performs the best to select for proteomics. As there are five cotton 
hydrolysate lots manufactured in 2016 by the company, these five lots has to 
be used in the cell culture to see how the performance of the cells was affected 
by these lots when compared to the soy hydrolysate and the normal media. 
For this purpose, each condition was run in duplicates, making it 14 flasks in 
total.  
 
Table 6: Experiment plan for Experiment 4 
Flask No. Condition Lot No. 
1,2 Control N/A 
3,4 0.4% Soy Hydrolysate SE50MAU 
5,6 0.4% Cotton Hydrolysate 100NTCR 
7,8 0.4% Cotton Hydrolysate 100PCHO 
9,10 0.4% Cotton Hydrolysate 100P1HW 
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11,12 0.4% Cotton Hydrolysate 100T1XJ 
13,14 0.4% Cotton Hydrolysate 100SZHT 
 
Cell culture performance results 
Testing all the new cotton lots for choosing the best candidate for 
proteomics analysis was the aim of this project. Five different cotton lots 
behaved in different ways and there was a winner among all the candidates. 
The cell density plot clearly shows that both NTCR and PCHO were good lots 
among the cotton lots tested. SZHT underperformed that soy hydrolysate and 
T1XJ along with P1HW performed similar to soy hydrolysate. Thus these 
three cotton hydrolysates were not considered for proteomics. Since the aim 
of this experiment was to select candidates for the proteomics analysis there 





Figure 13: Viable cell density for Experiment 4 
 
 




3.4.5 Experiment 5 
Four experiments have given enough evidence as to which lots of cotton 
hydrolysate should be selected for the proteomics and transcriptomics 
analysis. Based on the data we collected, it was decided to proceed with two 
cotton hydrolysate lots NTCR and PCHO for the -omics analysis. Thus, for 
the final experiment to get the samples for proteomics and transcriptomics 
analysis, each condition had four biological replicates, two flasks towards 
proteomics and two flasks towards transcriptomics. The scheme of 
experiment is given below. 
 
Table 7: Experiment plan for Experiment 5 
Flask Nos. Condition Lot No. 
1,2,3,4 Control N/A 
5,6,7,8 0.4% Soy Hydrolysate SE50MAU 
9,10,11,12 0.4% Cotton Hydrolysate 100NTCR 




Samples were collected to analyze for cell growth and viability along 
with metabolites viz. Glucose, glutamine, glutamate and lactate. Based on the 
cell count, cell sample containing 1 million cells was collected at two time 
points of the culture, mid exponential and early stationary phase for 
proteomics. So, we first take a sample for cell counting from the flask and 
then take another sample such that the total number of cells comes up to 1 
million. Later these cells need to be prepared to run the proteomics analysis 
and handed over to the facility at Hopkins. 
 
Cell culture performance results 
 After running four experiments with these cells and hydrolysates, there 
was a level of confidence in the results and the plots given below show that 
the results have not been surprising in any manner. The viable cell density plot 
showed the control to grow lesser when compared to the hydrolysate 
supplemented flasks. The maximum peak cell density was attained by the 
cotton hydrolysate to 100PCHO. 
 The glutamine and glutamate measurements showed us that, glutamine 
exhaustion time coincides with glucose exhaustion and lactate metabolic shift 
from production to consumption. There is an inverse correlation between 
glutamine and glutamate levels in the culture. The six plot shown below 
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summarizes the experimental run. From this experiment, 100PCHO from the 
cotton hydrolysate lots was decided to be sent for proteomics analysis as this 
















Figure 15: Cell culture characteristics of Experiment 5. (Top to Bottom 
plots in order) 1. Viability, 2. VCD, 3. Glucose concentration, 4. Lactate 
Concentration, 5. Glucose consumption rate, 6. Lactate consumption rate, 7. 
Glutamine concentration, 8. Glutamate concentration 
 
3.5      Post cell culture analysis: ELISA, BCA and SDS-GEL 
After the cell culture process and its growth performance has been 
completed, there needs to be an analysis of the IgG product that is generated 
by the batch culture. This would tell us if the hydrolysates are helping in 
increasing the productivity of CHO cells. This result of the protein 
productivity would put a final word on the decision to go for the proteomics 
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or not. Then following section will describe the Elisa protocols used for the 
experiment and further describe the proteomics related activities performed. 
 
3.5.1 ELISA (Enzyme-linked immunosorbent assay) 
The protein productivity of the cell culture was quantified using ELISA. 
The protocol detailed in Chapter 2 was used for the analysis. The samples of 
the last three days of cell culture in Experiments 4 and 5 were analyzed for 
protein productivity. The results of the assay are given below. There is a 
general trend seen in the analysis that, the culture no supplemented with any 
hydrolysate produced less quantity of IgG compared to the other flasks where 
there was hydrolysate supplementation. The IgG concentration reduced on the 
last day of culture since the viability of the culture crashed by that time and 






Until now, we have seen the effects of supplementing hydrolysates to 
the cell culture medium. The reason for this effect is still not know to us. This 
information could be obtained through proteomics analysis. Samples were 
collected during Experiment 5 on two days when the culture was in mid 
exponential phase (Day 5) and it was in early stationary phase (Day 6). The 
samples were processed according to the protocol detailed in Chapter 2. Later, 
BCA was performed on the samples to check for the total protein 
concentration in each sample. Depending on the total protein content, the 
loading volume would be determined for proteomics analysis. Later an SDS 
gel was run by the sample receiving Proteomics center and they have seen the 
spread of the sample to know what molecular weight range of proteins are 
present in the samples submitted. The samples have been submitted for 
proteomics analysis and the results are yet to be obtained for future analysis. 
The gel images for the SDS-PAGE analysis of the cell lysates utilized for 
proteomics run are shown below. The samples scheme is as follows: 
SK1 (Flask 1 Day 5 Control), SK2 (Flask 4 Day 5 Control), SK3 (Flask 1 Day 
6 Control), SK4 (Flask 4 Day 6 Control), SK5 (Flask 6 Day 5 Soy 
Hydrolysate), SK6 (Flask 7 Day 5 Soy Hydrolysate), SK7 (Flask 6 Day 6 Soy 
Hydrolysate), SK8 (Flask 7 Day 6 Soy Hydrolysate), SK9 (Flask 13 Day 5 
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100NTCR), SK 10 (Flask 16 Day 5 100NTCR), SK11 (Flask 13 Day 6 
100NTCR), SK 12 (Flask 16 Day 6 100NTCR) 
 
Figure 17: SDS-PAGE image for the samples submitted for proteomics. This 
gel was run by the proteomics center 
 
3.6       Summary 
Hydrolysates have proved to have improved the cell culture 
performance in terms of cell growth and productivity through the experiments 
conducted. Their supplementation is a good replacement to serum as the effect 
of serum is reproduced by using a hydrolysate. The present work has 
compared hydrolysates from two different sources in terms of effect on cell 
growth and productivity. The study also brought in the conclusion that there 
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is a lot to lot variability among the cotton hydrolysate sample. Each lot of 
cotton hydrolysate behaves in a different way. The productivity of hydrolysate 
supplemented culture is almost double and triple when compared to the 
productivity of the control batches. Once it was confirmed through 
experiments that the hydrolysates indeed are bringing in an improvement in 
culture performance and final productivity, the reason for this effect was 
decided to be explored. For this purpose, samples at two different time points 
were collected and sent for proteomics analysis. The results will give 
information on the proteome of the cell lysate which would enable us to map 
the pathways which are active in the cell. On comparing the proteomes of the 
soy and cotton hydrolysates with the control, there is hope to find some 
markers to cell growth and protein productivity to justify the effect produced 
by hydrolysate supplementation in the culture media. 
 
3.7     Future work 
 Hydrolysates, since their inception, as media additives have been used 
in both batch and fed batch processes. Their supplementation at different 
phases of cell culture is the major area of focus in the future work. The project 
demands the design of a fed-batch process using soy and cotton hydrolysates 
both in combination and individually. These experiments would throw light 
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on the nature of action of these hydrolysates in a fed batch setup. Once the 
proteomics data is obtained, pathway analysis will be performed to look for 
the pathways which have been upregulated and downregulated with the 
addition of hydrolysates form different sources. Achieving these goals would 
be on priority which would then conclude once a fed-batch process has been 
locked down for the given CHO cell line producing IgG.  
 There is also a necessity of a good, precise IgG assay for quantification 
since, the ELISA method provided by Friesland Campina is found to show a 
great amount of variability. The source of this variability should be eliminated 
and an optimized assay should be developed. Finally, the findings of this 











Chapter 4 MAMMALIAN CELL ENGINEERING ESSENTIAL 
AMINO ACIDS PATHWAYS 
 
4.1      Introduction 
Cells, in general, build higher level components like RNA, DNA from 
basic molecules like sugars and peptides. But a self-sufficient system should 
be built in a cell when a chemical system is built in it which is capable of 
replication and evolution with the help of small molecules. Such a cell system 
is called a minimal cell. Synthesizing a minimal cell would open many new 
paths in Bioprocess development. [17].  This ideology of self sufficiency 
exists in prokaryotic cells like bacteria. Incidentally, some of these pathways 
have evolved their way into higher eukaryotic cells. For instance, the division 
of amino acids into essential and non-essential amino acids is a result of 
evolution. The pathways of essential amino acids were lost when the 
eukaryotic organisms were formed. Compartmentalization in eukaryotic 
organisms was incorporated during this process of formation, which marks as 
one of the key difference between eukaryotes and prokaryotes [18]. 
Prokaryotic organisms have the ability to produce their own amino acids in a 
quantity that is necessary for the cell. This is another major difference between 
prokaryotes, like bacteria and yeast, and higher-level eukaryotes such as 
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mammalian cells. Surprisingly, the consumption of these essential amino 
acids is higher in mammalian cells. The amino acid demand for the 
prokaryotes is much less than that of eukaryotic cells [19, 20]. Figure below 
shows the amino acid pathways of biosynthesis for prokaryotic cells and 
Eukaryotic cells.  
 
Figure 18: Biosynthesis of amino acids 
 
Even though the essential amino acids are not produced by the 
mammalian cells, one-fourth (24.4%) of the amino acid content in the human 
body comprises of threonine and the three branched chain amino acids (valine, 
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isoleucine, leucine) [21].  Indeed, leucine, being an essential amino acid, has 
6 codons encoding which occurs in one another amino acid serine. It is 
interesting to note that some of the non-essential amino acids require more 
energy for synthesis than essential amino acids like valine and threonine. If 
synthesizing the essential amino acids is less energy intensive, the reason for 
eliminating them from the mammalian repository of biosynthesis is still not 
evident [22]. Bringing back these pathways lost pathways would reconstruct 
a minimal cell which would make the mammalian cell self sufficient. It would 
be informative from a metabolic and evolutionary perspective and beneficial 
from a biomanufacturing perspective to evaluate the impact of reconstructing 
essential amino acid pathways on human and, more generally, mammalian 
cell physiology using a synthetic biology paradigm. 
 
4.2      Aim 
Mammalian cell cultures need all the nine essential amino acids for 
their growth and maintenance: histidine, isoleucine, leucine, lysine, 
methionine, phenylalanine, threonine, tryptophan, and valine. Apart from this 
high demand for nutrients to survive, these mammalian cultures require 
energy for protein production. The nutrients supplied to the cells as cell 
culture media fulfills these requirements even though the cell possesses the 
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machinery to create these amino acids. In order to address these challenges 
within mammalian cell culture, reconstructing the leucine, isoleucine, and 
valine biosynthetic pathways in mammalian cell lines could eliminate the 
dependence of the mammalian cell on these amino acids. With the existing 
cell machinery, if a path is created for them to synthesize and control the 
production of amino acids, there might be a higher productivity of the protein 
because there would be extra available energy for the cells to produce the 
protein.  
The goal of the research described is to reconstruct the amino acid 
pathways for four essential amino acids: threonine, valine, isoleucine, and 
leucine in a Chinese hamster ovary (CHO) cell line, human embryonic kidney 
(HEK) cells. Since these biosynthetic pathways do not exist in the mammalian 
cells, they will be incorporated from cells which makes these amino acids by 
itself, the bacterial and yeast cells. The research work described here uses the 
biosynthetic genes of leucine, isoleucine and valine from yeast organism 
Saccharomyces Cerevisiae and clones them into a mammalian expression 
vector to eventually express them in two different mammalian cell lines. The 
cell lines chosen for research are highly significant for many reasons. Indeed, 
mammalian cell lines are responsible for the production of the vast majority 
of biotherapeutics including monoclonal antibodies, vaccines, and other 
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valuable biologics [23, 24]. In addition, cell lines such as HEK are used to 
supply complex mammalian membrane proteins needed in protein 
crystallography studies [25, 26].  
The cell line HEK also gives a major advantage when it comes to 
mammalian transfections. The initial expression studies for a gene are 
performed in HEK cell line since, these cell lines work best for transient 
transfections. While it is far more complex to express a gene transiently in 
CHO cell lines. Keeping this in mind, initial expression studies are always 
performed in HEK cell lines. When the genes are known to have expressed in 
HEK cell line, transfections are performed in CHO-K1 cells to later create a 
stable cell line creating its own essential amino acids.  
Three different amino acid biosynthetic pathways were dealt with in 
this study. Two sets of experiments were performed to achieve the following 
two aims: 
A. Since the genes of isoleucine and valine were individually expressed in 
HEK cell line by my teammate Nathan, expression of these genes in CHO 
cells was to be explored. Since CHO cell are more complex when 
compared to HEK, the transfection efficiency is less. The first aim of this 
study was to express the biosynthetic genes of isoleucine and valine cloned 
from yeast organism Saccharomyces Cerevisiae, in CHO cells. 
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B. The biosynthetic pathway of leucine, branched out from the precursor of 
valine. This pathway genes were aimed to be cloned into a mammalian 
expression vector and expressed in HEK cells. Once the expression was 
achieved in HEK cell line, the study could be extended to CHO cell lines 
where the transfection efficiency is low.  
The above two aims have been explored through molecular cloning 
techniques and various other protocols briefed in Chapter 2. The description 
of the amino acids worked with and the results of the study are detailed in the 
sections below.   
 
4.3 Branched chain amino acids Biosynthesis 
4.3.1 Leucine 
Leucine is an essential amino acid which is one of the three branched 
chain amino acids, with an isobutyl side chain resulting in its hydrophobicity. 
Leucine is the amino acid which is encoded by six codons, UUA, UUG, UUC, 
CUC, CUA, and CUG. The biosynthetic pathway of leucine in yeast is given 




Figure 19: Biosynthesis pathway of Leucine in Saccharomyces Cerevisiae 
[32] 
 
In Saccharomyces cerevisiae, leucine is produce from the precursor of 
valine, 2-keto-isovalerate. The pathway is four steps long and there are six 
genes which help in the biosynthesis of leucine. Two out of the six genes are 
present in the mammalian genome. It is interesting to note that, leucine 
regulates the pathway by feedback inhibition of the first dedicated step 
catalyzed by LEU4 and LEU9. Mutants which have reduced this inhibition 
and increased leucine production have been created by researchers [31]. 
 
4.3.2 Isoleucine 
 Isoleucine is a hydrophobic essential amino acid which is one of the 
three branched chain amino acids. The codons, AUU, AUC, AUA encode 
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Figure 20: Biosynthesis pathway of Isoleucine in Saccharomyces Cerevisiae 
[32] 
 
In Saccharomyces cerevisiae, isoleucine is produce from another 
essential amino acid, threonine. The pathway is five steps long and there are 
seven genes which help in the biosynthesis of leucine. Two out of the seven 
genes are present in the mammalian genome. The initial enzyme in the 
pathway, threonine deaminase (ILV1), is subject to feedback inhibition by 




Valine is an essential nonpolar branched chain amino acid (along with 
isoleucine and leucine) encoded by codons GUU, GUC, GUA and GUG. 
Valine is synthesized from pyruvic acid in the pathway shown below in Figure 
3 [27]. Valine is a four step biosynthetic pathway with six genes necessary to 
produce it. Pyruvate produced from glycolysis is the substrate of the first step 
towards valine biosynthesis. Two out of the six genes involved are present in 
the mammalian genome. In Saccharomyces Cerevisiae, isoleucine and valine 
are synthesized from the same set of genes, except for ILV1, which converts 
threonine to 2-oxobutanoate.  
The leucine biosynthesis pathway also utilizes the same pathway but 
diverges after 2-keto-isovalerate. Not surprisingly, the first dedicated step in 
the pathway catalyzed by acetolactate synthesis is feedback inhibited by both 
valine and leucine [28]. Degradation of valine and the other branched chain 
amino acids (BCAA) proceeds through the BC alpha-keto acid dehydrogenase 
complex. The complex degrades the BCAAs into Acyl-Co derivatives and 











4.4     Experimental and Results 
This section gives a detailed account of the different experiments that 
have been performed to achieve the aims (A) and (B). Experiment 1: The first 
set of experiments were the cloning of leucine genes into mammalian 
expression vector. The mammalian cloning procedure described in Chapter 2 
was followed to clone four genes that are a part of leucine biosynthesis 
pathway in yeast, into mammalian expression vector.  
 Experiment 2: After the genes were successfully cloned six clones for 
each gene were created and sequenced for confirming the presence of the 
gene. Out of all the clones that were created, transfection experiments were 
performed to eliminate the clones which could not give the final protein 
product.  
Experiment 3: For the isoleucine and valine pathway genes, after the 
expression was confirmed in HEK cells, transfection experiments were 
performed to express the individual genes in CHO-K1 cells. As isoleucine and 
valine have the same set of genes for biosynthesis, one single experiment was 
performed for expressing them.  
The sections below will give a detailed account of both the experiments 
and the extent of success achieved through these experiments. The results of 
the experiments are also explained in detail. 
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4.4.1 Experiment 1 
 Four genes from yeast genome are necessary for the biosynthesis of 
leucine: LEU1, LEU2, LEU4, LEU9.  The mammalian expression vector 
pBUD CE4.1 has two different multiple cloning sites which have a various 
restriction sites that were used for cloning the four genes. Design of primers 
was based on the vector map given in the figure below. 
 
 
Figure 22: Vector map of pBudCE4.1, mammalian expression vector used in 




Though the vector is tagged with epitopes, it was recommended for 
designing the primers of the gene along with the epitope tag. Thus every gene 
was tagged with 6X Histidine which is the shortest epitope tag and it is known 
to not interfere with the functionality of the gene. The forward and reverse 
primers designed for the four genes and their respective annealing 
temperatures and GC content are given in the table.  
  PCR was performed with the primers designed with the protocol 
detailed in chapter 2 The output of the PCR was tested using gel 
electrophoresis. The ladder used for the gel electrophoresis is ‘Generule 1kb 
plus DNA ladder’. The path of the ladder is shown in the figure below. 
 




Figure 24: Primers used for PCR in leucine biosynthesis pathway 
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The gel images under 60% UV light are given in the images below. 
The ladder was loaded in every gel for a better accuracy of the location of 
the gene. 
LEU1 (Isopropyl malate isomerase) catalyzes the conversion of 2-
isopropylmalate to 3-isopropylmalate and it is localized to the cytosol. The 
length of the gene is 2340 base pairs. The length of the insert including the 
restriction enzymes and the epitope tag along with the extra base pairs would 
be around 2360 base pairs. The gel image shows two sample tubes of PCR 
containing the insert of LEU1 gene. 
 
Figure 25: Agarose gel result Samples from left to right: DNA Ladder, 
LEU1 PCR Product samples 
 
LEU2 (3-isopropylmalate dehydrogenase) catalyzes the third step in the 
leucine biosynthesis pathway; can additionally catalyze the conversion of 
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beta-ethyl malate into alpha-ketovalerate. The length of the gene is 1095 base 
pairs. The length of the insert including the restriction enzymes and the 
epitope tag along with the extra base pairs would be around 1120 base pairs. 




Figure 26: Agarose gel result of LEU 2, samples from left to right: LEU2 
PCR product samples, DNA ladder 
 
LEU4 (2-isopropylmalate synthase) the main isozyme responsible for 
the first step in the leucine biosynthesis pathway; LEU4 has a paralog, LEU9, 
that arose from the whole genome duplication. The length of the gene is 1860 
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base pairs. The length of the insert including the restriction enzymes and the 
epitope tag along with the extra base pairs would be around 1900 base pairs. 
The gel image shows two sample tubes of PCR containing the insert of LEU4 
gene. 
 
Figure 27: Agarose gel image of LEU4 and LEU 9, smples from left to right: 
DNA Ladder, LEU9 PCR Product sample (one), LEU4 PCR product 
samples (Two) 
 
LEU9 (Alpha-isopropylmalate synthase II or 2-isopropylmalate 
synthase) catalyzes the first step in the leucine biosynthesis pathway. This 
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minor isozyme of LEU4 is responsible for the residual alpha-IPMS activity 
detected in a leu4 null mutant. LEU9 has a paralog, LEU4, that arose from the 
whole genome duplication. [Casalone E, et al. (2000) Identification by 
functional analysis of the gene encoding alpha-isopropylmalate synthase II 
(LEU9) in Saccharomyces cerevisiae. Yeast 16(6):539-45]. The length of the 
gene is 1815 base pairs. The length of the insert including the restriction 
enzymes and the epitope tag along with the extra base pairs would be around 
1850 base pairs. The gel image shows one sample tube of PCR containing the 
insert of LEU9 gene. 
 These four inserts obtained from PCR were cloned into the mammalian 
expression vector pBudCE 4.1 and transformed to produce six clones for each 
gene. These clones were sequenced and our of all 24 clones, 17 clones had the 
respective genes in the right place on the plasmid. These clones were used to 
perform the expression studies. 
 
4.4.2 Experiment 2 
The 17 clones sequenced to find the right gene from experiment 1 were 
used to perform expression studies. HEK cells were plated and transfected in 
a 6 well plate. The scheme of the experiment in the 6 well plates is shown in 























































































































The results were analyzed in two ways using an SDS-PAGE gel and 
subsequent staining of the gel using Coomassie Blue, and a western blot. 
Coomassie Blue staining was a preliminary study to check if the protein of 
interest was present or not. Unfortunately, the stained gels could not provide 
any point of differences when compared to the control. The ladder used for 
the gel image is ‘Spectra Multicolor Broad Range Protein Ladder’. The image 
of the ladder is given below. 
 
Figure 28: Protein ladder used for SDS-PAGE analysis 
 
Figure 1 shows the gel with LEU1 and LEU9 clones. Sample order from left 
to right is as follows: 
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Ladder  Control  LEU1 Clone 1  LEU1 Clone 4  Blank LEU9 
Clone 1  LEU9 Clone 4  LEU9 Clone 5  LEU9 Clone 6. The protein 
formed from LEU9 is 67kDa in size and that of LEU1 is 86kDa. 
  
Figure 29: SDS-PAGE gel image stained with Commasie Blue of LEU1 and 
LEU9 gene clones 
 
Figure 2 shows the gel with LEU2. Sample order from left to right is as 
follows:  Control  Ladder  LEU2 Clone 1  LEU2 Clone 2  LEU2 
Clone 3  LEU2 Clone 4  LEU2 Clone 5  LEU2 Clone. The size of the 




Figure 30: SDS-PAGE gel image stained with Commasie Blue of LEU2 
Figure 2 shows the gel with LEU4. Sample order from left to right is as 
follows:  Control  LEU4 Clone 1  Ladder  LEU4 Clone 2  LEU4 
Clone 3  LEU4 Clone 4  LEU4 Clone 5. The size of the protein translated 




Figure 31: SDS-PAGE gel image stained with Commasie Blue of LEU4 gene 
clones 
 Since the gel staining could not provide valuable information regarding 
expression, western blotting was performed on the clones of LEU4 gene to 
check if the genes were expressed or not. The blotted membrane was 
incubated with ‘Rabbit IgG anti-HIS antibody’ as the primary antibody and 
the secondary antibody used was ‘Anti-rabbit IgG-HRP conjugated’. Then the 
image was taken using chemiluminescence techniques. Three clones out of 
the six clones transfected showed an expression of the gene translated by 




Figure 32: Western blot result showing the expression of LEU4 protein in 
three clones out of five clones transfected 
 
4.4.3 Experiment 3 
 The 5 genes involved in the biosynthesis of isoleucine and valine were 
previously expressed in HEK 293T cell line. In this experiment, we have 
transfected these genes into CHO-K1 wild type cells. Cells were grown in a 6 
well plate till the reached a 70% to 90% confluence. The plasmid containing 
ILV1, ILV2, ILV3, ILV5 and ILV6 were transfected using lipofectamine 




















The results were analyzed in two ways using an SDS-PAGE gel and 
subsequent staining of the gel using Coomassie Blue, and a western blot. 
Coomassie Blue staining was a preliminary study to check if the protein of 
interest was present or not. Unfortunately, the stained gels could not provide 
Control ILV1 ILV2 
Control ILV1 ILV2 
ILV3 ILV5 ILV6 
ILV3 ILV5 ILV6 
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any point of differences when compared to the control. The ladder used for 
the gel image is ‘Spectra Multicolor Broad Range Protein Ladder’. The image 
of the stained gel is given below. The order of sample from left to right is: 
CHO-K1 Control  ILV1  ILV2  Ladder  ILV3  ILV5  ILV6 
 
Figure 33: SDS-PAGE gel image stained with Coomassie Blue of ILV1, 
ILV2, ILV3, ILV5 and ILV6 genes transfected into CHO-K1 
 
Since the gel staining could not provide valuable information regarding 
expression, western blotting was performed on all the genes to check if they 
were expressed or not. The blotted membrane was incubated with ‘Goat-IgG 
anti-V5 antibody’ and ‘Rabbit-IgG anti-HIS antibody’ as the primary 
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antibody and the secondary antibody used was ‘Anti-goat IgG-HRP 
conjugated’ and ‘Anti-rabbit IgG-HRP conjugated’. Then the image was 
taken using chemiluminescence techniques. The figure below shows the 
results. The bands that appear from left to right are ILV6, ILV5, ILV3 and 
ILV2 respectively. The expression of ILV1 is not seen thus it is concluded 
that ILV1 could not be expressed in CHO-K1 cells.  
 
Figure 34: Western blot of isoleucine valine genes transfected into CHO-K1 
wild type. Samples order from left to right: ILV6, ILV5, ILV3, ILV2 and 
ILV1 was not expressed 
 The discrete band that we see in the samples ILV2 and ILV3 has been 
a characteristic of the cloned gene since this pattern was also observed when 




Experiment 3 in terms of the positions of the band relative to the ladders in 
the above figure. 
 
4.5     Summary 
 The issue of expensive media requirements continues to represent one 
of the major cost barriers to biopharmaceuticals for patients.  If we could 
augment the synthetic capabilities of CHO cells to enable the production of 
key amino acids and other building blocks not naturally present, we would 
have the potential to transform the most important bioproduction platform 
currently available.  Such a change would lead to a simpler media requirement 
for the CHO production platform, leading to lower costs to patients for life-
saving monoclonal antibodies and other biopharmaceuticals. As a part of this 
change, the current research explored the essential amino acid producing 
capability of mammalian cells. Two aims were achieved in this respect. The 
branched chain amino acid (Leucine, Isoleucine and valine) biosynthesis 
pathway genes from yeast were cloned into mammalian expression vector and 
expressed in mammalian cells. The success of the experiments performed 
prove that prokaryotic amino acid genes could be expressed in mammalian 
cells and thus there is a possibility that these cells can produce their own 
amino acids when the pathway is engineering fully into the cell. These results 
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also provide us with a hope that, a minimal mammalian cell could one day be 
created such that it would not require any amino acid supplementation for 
growth and maintenance. 
 
4.6     Future work 
 The ideology behind the research work described in the previous 
sections is an ocean whose exploration has just begun. There are 9 different 
essential amino acids which should be targeted. There are various challenges 
that researchers are facing when the biosynthetic genes are expressed together. 
This is impeding the development of cell lines which make their own amino 
acids. Cell-free systems have started being useful for synthetic biology 
research. Problems that could not be solved in vivo are being tackled in vitro 
because, the system converts into a chemical assembly rather than a biological 
assembly once the term cell-free comes into play. For instance, the isoleucine 
and valine pathway could produce the first intermediate but not the second 
intermediate when all the genes were transfected into a single well. If this 
reaction was performed in vitro, the information on the lacking component is 
easy to obtain. Thus cell-free systems provide a direction to find answers in 
this difficult problem statement. 
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 Multicistronic plasmids using IRES could be created combining all the 
genes together into one single plasmid and checked for expression. This 
direction if works, would create stable cell lines producing amino acids. The 
future of this project could take two directions and both the directions will be 

















Chapter 5 CONCLUSION 
 
Biopharmaceuticals around the world always work towards a higher 
throughput in a process they design, be it a upstream bioprocess, a 
downstream purification step or the final fill finish process. When it comes to 
upstream bioprocess improvement, target is set on increasing the productivity 
of the cells with minimal uptake of cell nutrients from outside. These two 
aspects have been explored in the research described in the current thesis.  
Chapter 1 introduced the thesis aim and gave a brief background on 
various aspects of mammalian cell culture relevant to the current research 
work. All the protocols that have been used in the work are detailed in Chapter 
2. These protocols were adopted from various cell culture websites and have 
been provided by the reagent suppliers like Sigma Aldrich, Thermo Fisher 
Scientific and New England Biolabs. 
The productivity of the cells can be improved through various 
techniques. Changes can be made in the equipment used for culturing cells 
such that the mass transfer in the cultures is improved as in wave bag 
bioreactor, or the nutrients could be replenished at a regular basis through a 
perfusion system. These options involve heavy capital to begin with since the 
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equipment to be procured is expensive. The use of additives is the most 
economical option to pursue for improving the productivity of the cells. One 
such additive was manufactured and provided by Friesland Campina to 
explore its effect on the cell culture performance. The additives, hydrolysates, 
were used in the cell culture at a final concentration of 0.4% and we have seen 
a two to threefold increase in the productivity of the cells. While soy 
hydrolysate doubled the productivity along with the cell growth, cotton 
hydrolysates have increased it three times when compared to the control flasks 
not supplemented with any hydrolysates. Cell growth is also improved and 
the cells have a nutrient boost when hydrolysates are supplemented in the 
culture media. A trend observed in the hydrolysate cultures is that, they run 
out of glucose on day 6 and later the cells crash on day 8 to zero viability form 
a viability greater than 90%. Since the effect of hydrolysates was tested in a 
batch process, there was no possibility of adding extra nutrients like 
supplementing the cultures with glucose and glutamine as the primary energy 
source.  
Five different lots of cotton hydrolysates were tested simultaneously as 
media supplements for a lot variability study. It was surprising to note that 
every lot of cotton hydrolysate behaved in a different manner but none of the 
lots underperformed when compared to the control and soy hydrolysate 
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supplemented flasks. The cotton lots 100NTCR and 100PCHO performed the 
best among the five lots tested in terms of both cell growth and IgG 
productivity. Both these lots were selected to perform proteomics analysis on 
the hydrolysate samples to understand the mode of action of these 
hydrolysates when added to the cell cultures. The research performed on 
hydrolysates brought in confidence that, the deficiency created in the cell 
culture media due to the elimination of serum and compensating it with 
chemical formulations could be fulfilled by hydrolysates. Companies like 
Sigma Aldrich and Lonza, who are one of the leaders in the market of cell 
culture media, have already started exploring the potential of hydrolysates and 
a few media formulations are known to have hydrolysate supplemented in 
them. The future of hydrolysates looks promising in the cell culture industry. 
The second major aspect of concern for the biopharmaceutical 
industries is to make the cells that produce their desired product self-
sufficient. This would obviate media formulations with optimal amounts of 
various components and allow the cell to produce what it needs for its survival 
and maintenance. As the first step towards this end goal, essential amino 
acids’ biosynthetic pathways were to be engineered into mammalian cells. In 
particular, the research described in the thesis targeted branched chain amino 
acids- Leucine, Isoleucine and Valine. The biosynthetic pathway genes were 
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cloned into mammalian expression vector and transfected into mammalian 
cells to check for expression. All the genes were cloned into the mammalian 
expression vector pBUD4.1 and later transfected into CHO-K1 and HEK 
293T cell lines and their expression was tested using a western blot. Five out 
of the nine genes to be expressed, have worked. Out of these five genes, one 
was the gene for leucine biosynthesis, LEU4 and it was expressed in HEK 
293T. The other four genes were from the isoleucine and valine pathway 
which were expressed in CHO-K1. These results of expression prove that 
prokaryotic genes could be expressed in eukaryotic organisms. New cell lines 
could be generated with non-dependence on the amino acids which are 
essential for growth, which would be our final target in this project. 
 Continued efforts to improve both the research statements will be put 
in through further experimentation as described in the Future works sections. 
Bioprocess development will benefit through the success of these research 
works leading to high throughput bioprocessing and thereby reducing the cost 
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